| Ticker Details |
|
bioAffinity Technologies, Inc.
|
| IPO Date: |
September 1, 2022 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$4.86M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.09 | 5.15%
|
| Avg Daily Range (30 D): |
$0.06 | 6.06%
|
| Avg Daily Range (90 D): |
$0.08 | 4.90%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.81M |
| Avg Daily Volume (30 D): |
.2M |
| Avg Daily Volume (90 D): |
.38M |
| Trade Size |
| Avg Trade Size (Sh.): |
154 |
| Avg Trade Size (Sh.) (30 D): |
244 |
| Avg Trade Size (Sh.) (90 D): |
164 |
| Institutional Trades |
| Total Institutional Trades: |
13 |
| Avg Institutional Trade: |
$1.29M |
| Avg Institutional Trade (30 D): |
$1.27M |
| Avg Institutional Trade (90 D): |
$1.27M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$10.4
|
$-4.74
|
$-.17
|
|
Diluted EPS
|
$10.4
|
$-4.74
|
$-.17
|
|
Revenue
|
$6.78M
|
$1.45M
|
$1.27M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-14.74M
|
$-5.05M
|
$-4.06M
|
|
Operating Income / Loss
|
$-10.38M
|
$-2.29M
|
$-2.52M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$6.91M
|
$6.87M
|
$.36M
|
|
PE Ratio
|
0.11
|
|
|
|
|
|